Study setting {9}
The potential subjects will be recruited among college students in the Department of Rehabilitation Therapy at the Fifth Affiliated Hospital of Guangzhou Medical University in China by flyers. All recruited subjects will be asked to sign an informed consent form. The lead author (HNO) has the final approval of a subject’s eligibility. The subjects may choose to discontinue their participation at any time.
Eligibility criteria {10}
The inclusion criteria include subjects aged 18-26 years old in which the International Physical Activity Questionnaire (IPAQ) indicates good health. Subjects should have no professional sports experience, the ability to perform a CPET on a cycle ergometer and be willing to sign the informed consent. The exclusion criteria are a medical history of cardiovascular and respiratory diseases, subjects who fail to pass the IPAQ pre-exercise risk screening, and/or those who confirm that they cannot participate in high-intensity exercise.
Who will take informed consent? {26a}
The potential subjects will be recruited among college students in the Department of Rehabilitation Therapy at the Fifth Affiliated Hospital of Guangzhou Medical University in China by flyers. All recruited subjects will be asked to sign an informed consent form.
Additional consent provisions for collection and use of participant data and biological specimens {26b}
Not applicable as no biological specimens were collected as part of this trial.
Interventions
Explanation for the choice of comparators {6b}
We used a surgical mask due to its ubiquitous use in both hospitals and the community in the context of respiratory infectious disease pandemic. Group 1 will receive an intervention protocol (CPET with surgical mask) followed by 2-7 days of washout period and then a control protocol (CPET without surgical mask). Group 2 will receive the opposite sequence of interventions. All the subjects will receive two CPETs with and without surgical mask.
Intervention description {11a}
Cardiopulmonary exercise test (CPET)
CPET will be performed in an electromagnetic braking cycle ergometer (Corival®, LODE BV Medical Technology, Groningen, Netherlands). Before the test, each subject will be familiarized with routine testing instructions; their age, height, and weight will also be collected.
Resting pulmonary function tests will be performed to determine parameters such as forced vital capacity (FVC), first second forced expiratory volume (FEV1), FEV1% (% of the expected value), FEV1/FVC, and maximum volume (MVV).
Subjects then will perform a ramp CPET on a cycle ergometer. The exercise protocol consists of the following stages[6]: 2 min for resting stage, 2 min for warm-up stage (unloaded cycling), 8-12 min cycling for testing stage (ramp exercise, 5-30 watts per min), 3 min cool-down stage (unload cycling), and 7 min rest for monitor stage. During the testing period, bicycle loading is constantly increased by 15-30 Watts per minute according to anticipated physical capacity, gender, age, body mass, and self-reported physical activity status. The heart rate (HR) and pulse oxyhemoglobin saturation (SpO2) are continuously recorded. Blood pressure (BP) will be measured every two minutes of exercise. Dyspnea and lower limb fatigue scores will be assessed via the modified Borg scale when the patient is at rest and immediately after stopping the exercise session. Subjects are encouraged to exercise to their maximum endurance or until the practitioners ended the exercise due to symptoms like ischemic ECG changes, complex ectopy, second or third degree heart block, fall in systolic pressure > 20 mm Hg from the highest value during the test, hypertension (> 250 mm Hg systolic; > 120 mm Hg diastolic), severe desaturation (SpO2 ⩽ 80%), symptoms and signs of severe hypoxemia (sudden pallor, loss of coordination, mental confusion, dizziness, faintness), and signs of respiratory failure. The test will be terminated immediately if the subjects show extreme verbal or physical fatigue.
Simultaneous surface electromyography (EMG)
Surface EMG data are simultaneously collected using the BTS FREEEMG 1000 (BTS Bioengineering Spa, Italy) device with surface electrodes during the CPET. It has a 120 dB common mode rejection ratio (CMRR) and a 16-bit A/D resolution. The sampling rate is 1000 Hz per channel. Pre-gelled bipolar silver/silver chloride surface electrodes are fixed over the muscle bellies and aligned parallel to the underlying muscle fiber direction with an inter-electrode distance of 20 mm. The electrodes will be attached on the tibialis anterior (TA), lateral gastrocnemius (LG), medial gastrocnemius (MG), rectus femoris (RF), vastus medialis (VM), vastus lateralis (VL), semitendinosus, and biceps femoris (BF) in the dominant lower limb. Each electrode attachment region is identified using anatomical landmarks via a qualified physiotherapist. Fat and perspiration in the skin can make it difficult to paste electrodes and increase the impedance. The gauze dipped with alcohol is used to rub the skin at fixation sites after shaving the subject's skin to eliminate them and reduce impedance.
Criteria for discontinuing or modifying allocated interventions {11b}
Subjects are encouraged to exercise to their maximum endurance or until the practitioners ended the exercise due to symptoms like ischemic ECG changes, complex ectopy, second or third degree heart block, fall in systolic pressure > 20 mm Hg from the highest value during the test, hypertension (> 250 mm Hg systolic; > 120 mm Hg diastolic), severe desaturation (SpO2 ⩽ 80%), symptoms and signs of severe hypoxemia (sudden pallor, loss of coordination, mental confusion, dizziness, faintness), and signs of respiratory failure. The test will be terminated immediately if the subjects show extreme verbal or physical fatigue.
Strategies to improve adherence to interventions {11c}
Not applicable as this study is just the immediate effect study and the assessment for normal subjects.
Relevant concomitant care permitted or prohibited during the trial {11d}
Not applicable as the potential participants are all normal healthy subjects.
Provisions for post-trial care {30}
Not applicable as this study is just focus on the comparison two times of CEPT assessments in normal young subjects and does not include any intervention with potential harm after the assessment.
Outcomes {12}
Primary outcome
Maximum oxygen uptake (VO2 max) is the primary outcome from CPET and was performed on a cycle ergometer—this is the most important parameter associated with an individual's physical conditioning [7].
Secondary outcomes
- Parameters reflecting exercise tolerance and heart function: oxygen uptake, anaerobic valve, maximum oxygen pulse, heart rate reserve.
- Parameters reflecting ventilation function: respiration reserve, ventilation volume, tidal volume, breathing frequency.
- Parameters reflecting gas exchange: end-tidal oxygen and carbon dioxide partial pressure, oxygen equivalent, carbon dioxide equivalent, and the relationship between dead space and tidal volume.
- Parameters reflecting skeletal muscle function: oxygen uptake, anaerobic valve, work efficiency, and EMG parameters including root mean square (RMS), and median frequency (MF).
Participant timeline {13}
Summarized study schedule at each visit in the clinical trial including the enrolment, interventions, and assessments is shown in Figure 1.
Sample size {14}
We could not find in the literature any data on normal subjects wearing masks undergoing CPET in the literature. Thus, we did a ten-subject roughly preliminary experiment. We assumed an alpha risk of 0.05, a beta risk of 0.95, and a mean difference in VO2 max between the 2 CPETs (with and without wearing mask) of 11.7 (SD 13.27) mL/kg. The results suggest that 44 subjects are required (G*Power 3.1.92). Therefore, 50 subjects will be recruited considering a 10% drop-out rate.
Recruitment {15}
The potential subjects will be recruited among college students in the Department of Rehabilitation Therapy at the Fifth Affiliated Hospital of Guangzhou Medical University in China by flyers.
Assignment of interventions: allocation
Sequence generation {16a}
This study protocol followed the Standard Protocol Items for Randomized Trials (SPIRIT) [8]. The recruited subjects will be randomly allocated into two groups according to a sample randomization sequence generated via SPSS statistical software package (version 25.0).
Concealment mechanism {16b}
Not applicable as this study is cross-over designed with randomly of order with or without masks and blind methods are not involved.
Implementation {16c}
Not applicable as this study is cross-over designed with randomly of order with or without masks and blind methods are not involved.
Assignment of interventions: Blinding
Who will be blinded {17a}
Not applicable as this study is cross-over designed with randomly of order with or without masks and blind methods are not involved.
Procedure for unblinding if needed {17b}
Not applicable as this study is cross-over designed with randomly of order with or without masks and blind methods are not involved.
Data collection and management
Plans for assessment and collection of outcomes {18a}
All data are collected according to the participant timeline by two trained practitioners: one for cardiopulmonary data collection and the other for surface EMG data collection. The BTS EMG-Analyzer (BTS engineering, version 2.9.37.0, Italy) will be used for data analysis of the surface EMG signals. First, all raw EMG signals will be filtered using a band-pass filter (10 -300 Hz) and RMS envelope with a window of 100 ms 9. Every muscle of every subject will be analysed for ten consecutive crank revolutions in each stage based on the CPET protocol including resting stage, warm-up stage (unloaded cycling), testing stage (ramp exercise), cool-down stage (unload cycling), and monitor stage (recovery and monitor). The RMS data will be normalized to the peak of the average RMS curves of ten consecutive crank revolutions for each muscle of every subject 10. RMS usually indicates the activity of muscles, and a high RMS corresponds to high muscle activity. Moreover, within applied EMG-frequency analysis, MF is calculated as the mathematical mean of the spectrum curve: this is indicating the level of muscle fatigue and therefore shows a decrease in MF from the initial status. The results will be used to indicate increased muscle fatigue during operation.
Plans to promote participant retention and complete follow-up {18b}
Not applicable as this study does not involve follow-up.
Data management {19}
Quality of data will be conducted by research personnel once data collection is complete.
Confidentiality {27}
We will store all data including the data with personal identifiers in a password-protected lab server only accessible to the researchers. The data could be downloaded for statistical analysis on a computing system maintained by the Guangzhou Medical University in China.
Plans for collection, laboratory evaluation and storage of biological specimens for genetic or molecular analysis in this trial/future use {33}
Not applicable as no biological specimens are collected as part of this trial.
Statistical methods
Statistical methods for primary and secondary outcomes {20a}
The data will be analyzed using SPSS software (version 25, IBM Crop., Armonk, NY, USA) and the methodology referenced our previous study[9]. Parametric data will be presented as means and standard deviation (SD) if normally distributed or median if not. An ANOVA with a two-stage crossover will be used. Three factors will be considered for the experimental effect: the type of intervention (wearing masks or not wearing masks), the experimental periods (period I and period II), and individual differences in subjects. The paired t-test will be used to compare the differences of CPET parameters and surface EMG values between subjects with and without a mask. The correlation between VO2 max and median frequency of muscles will be analyzed with linear regression to explore the effect of VO2 max on the muscle fatigue during aerobic exercise based on the mask intervention. Statistical significance is p < 0.05. The results will be plotted with GraphPad Prism (version 8.4.2). We will not perform any interim analysis.
Interim analyses {21b}
Not applicable as this study does not involve interim analysis.
Methods for additional analyses (e.g. subgroup analyses) {20b}
Not applicable as this study does not involve additional analysis.
Methods in analysis to handle protocol non-adherence and any statistical methods to handle missing data {20c}
We will exclude the subject who have missing data directly.
Plans to give access to the full protocol, participant level-data and statistical code {31c}
This document is the full protocol. Anyone interested in de-identified data or documentation should contact the corresponding author.
Oversight and monitoring
Composition of the coordinating center and trial steering committee {5d}
Not applicable this study does not involve coordinating center or trial steering committee.
Composition of the data monitoring committee, its role and reporting structure {21a}
Not applicable this study does not involve data monitoring committee.
Adverse event reporting and harms {22}
Not applicable as this study just plans to recruit the normal subjects and perform widely clinical used CEPT assessment.
Frequency and plans for auditing trial conduct {23}
Not applicable as this study is the cross-over designed and does not need auditing trial conduct.
Plans for communicating important protocol amendments to relevant parties (e.g. trial participants, ethical committees) {25}
Not applicable as this study is simple cross-over designed for CEPT assessment and does not need protocol amendments.
Dissemination plans {31a}
We will disseminate the study findings through journal publications and conference presentations.